C, R., E, N., L, G., LL, O., M, S., Y, Z., . . . M, C. (2026). Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value. Science translational medicine, 18(840), eadw7698. https://doi.org/10.1126/scitranslmed.adw7698
Chicago Style (17th ed.) CitationC, Reduzzi, et al. "Dual-positive CTCs in Patients with Advanced Breast Cancer Show Metastatic Potential and Prognostic Value." Science Translational Medicine 18, no. 840 (2026): eadw7698. https://doi.org/10.1126/scitranslmed.adw7698.
MLA (9th ed.) CitationC, Reduzzi, et al. "Dual-positive CTCs in Patients with Advanced Breast Cancer Show Metastatic Potential and Prognostic Value." Science Translational Medicine, vol. 18, no. 840, 2026, p. eadw7698, https://doi.org/10.1126/scitranslmed.adw7698.